Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Atherosclerosis. 2015 Sep 21;243(1):278–285. doi: 10.1016/j.atherosclerosis.2015.09.025

Figure 3. Metabolic syndrome (MetS) severity by timing of initiation of medications.

Figure 3

Mean MetS severity Z-score by use of medications to treat blood pressure (A), lipids (B), diabetes (C) or a combination of these treatments (D) among ARIC participants by use of who never took the individual class of medication or who started the medication (or combination) at visit 1–4, as shown. In each case, individuals with baseline diabetes were excluded.